SDZNY SANDOZ GROUP AG S/ADR Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
11:55
Jul 22
Chloe Meley Reporter, Bloomberg Bloomberg Markets
Trump tariffs threaten generic drug margins
Trump's threat of 100% tariffs on generic drugs could push up costs and squeeze already thin margins, weighing on generic drug makers like Sandoz.
SDZNY 1ST
MED
09:56
Mar 10
@business
Sandoz is making a clear strategic move to capture a large, defined market opportunity as $650B worth of drugs come off patent.
SDZNY
MED

About SDZNY Analyst Coverage

Buzzberg tracks SDZNY (SANDOZ GROUP AG S/ADR) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: Chloe Meley, @business.